Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical ...

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical ...

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in ...

Shares of Alembic Pharmaceuticals came under pressure on Friday, falling 4.22 per cent to an intraday low of ₹776.20 per share on the NSE, after the company reported a 4 per cent decline in ...

Alembic Pharmaceuticals Ltd on Friday said it has received approval from the US health regulator for its generic version of Carbidopa, Levodopa and Entacapone tablets used in treatment of Parkinson's ...

Alembic Pharmaceuticals reported a steady operating performance in Q3, with revenue rising 10.8% year-on-year to ₹1,876.3 crore, supported by consistent execution across domestic and international ...

Alembic Pharmaceuticals Limited on Friday, February 6, said it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ...

SimFin is a database with financial data such as Income Statements, Balance Sheets and Cash Flow Statements, along with a simple Python API for downloading and using the data. These tutorials show how ...

Feel free to request an issue on github if you find bugs or request a new feature. Your valuable feedback is much appreciated to better improve this project. If you find this useful, please give it a ...